Brainstorm Cell Therapeutics Inc. entered into a Securities Purchase Agreement to sell registered shares of common stock, pre-funded warrants, and unregistered warrants, yielding gross proceeds of approximately $4.0 million.
AI Assistant
BRAINSTORM CELL THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.